Vascular endothelial growth factor synthesis in vascular smooth muscle cells is enhanced by 7-ketocholesterol and lysophosphatidylcholine independently of their effect on nitric oxide generation

This publication has 36 references indexed in Scilit:

• Peroxisome Proliferator–Activated Receptor-γ Ligands Inhibit Nitric Oxide Synthesis in Vascular Smooth Muscle Cells
  Hypertension, 2000
• Vascular Protection
  Arteriosclerosis, Thrombosis, and Vascular Biology, 2000
• Vascular endothelial growth factor is efficiently synthesized in spite of low transfection efficiency of pSG5VEGF plasmids in vascular smooth muscle cells
  Vascular Medicine, 2000
• Production of Vascular Endothelial Growth Factor by Murine Macrophages
  The American Journal of Pathology, 1998
• Oxidized low density lipoprotein inhibits lipopolysaccharide-induced binding of nuclear factor-kappaB to DNA and the subsequent expression of tumor necrosis factor-alpha and interleukin-1beta in macrophages.
  Journal of Clinical Investigation, 1996
• Oxidized LDL Induces Transcription Factor Activator Protein–1 but Inhibits Activation of Nuclear Factor–κB in Human Vascular Smooth Muscle Cells
  Arteriosclerosis, Thrombosis, and Vascular Biology, 1995
• Hypoxia and platelet‐derived growth factor‐BB synergistically upregulate the expression of vascular endothelial growth factor in vascular smooth muscle cells
  FEBS Letters, 1995
• Therapeutic angiogenesis. A single intraarterial bolus of vascular endothelial growth factor augments revascularization in a rabbit ischemic hind limb model.
  Journal of Clinical Investigation, 1994
• The pathogenesis of atherosclerosis: a perspective for the 1990s
  Nature, 1993
• Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis
  Nature, 1992